AITL	angioimmunoblastic T-cell lymphoma
Allo-HSCT	allogeneic-HSCT
AMLs	Acute Myeloid Leukemias
APL	acute promyelocytic leukemia
BM	bone marrow
CAR-T	chimeric antigen receptor T
CBF	core binding factor
cfDNA	cell-free DNA
cHL	Classical Hodgkin lymphoma
CLL	Chronic Lymphocytic Leukemia
CML	Chronic myeloid leukemia
CNS	central nervous system
CR	complete remission
DLBCL	Diffuse Large B-Cell Lymphomas
dPCR	digital PCR
ddPCR	droplet digital PCR
ET	essential thrombocythemia
FA	fractional abundance
FFPE	formalin-fixed paraffin-embedded
FISH	fluorescence in situ hybridization
FL	Follicular Lymphoma
FLA	Fragment length analysis
FU	follow-up
HSCT	hematopoietic stem cell transplantation
IgH	immunoglobulin heavy chain
MC	mixed chimerism
MCL	Mantle Cell Lymphoma
MF	Myelofibrosis
MLPA	Multiplex ligation-dependent probe amplification
MM	Multiple Myeloma
MRD	Minimal Residual Disease
NGS	Next-Generation Sequencing
OS	Overall survival
PAI	preferential allelic imbalance
PB	peripheral blood
PC	plasma cells
PCNSL	central nervous system lymphomas
PFS	progression-free survival
Ph- MPNs	Philadelphia negative chronic Myeloproliferative Neoplasms
PMBCL	primary mediastinal large B cell lymphoma
PNA-LNA	peptide nucleic acid-locked nucleic acid
PNQ	positive not-quantifiable
PTCL	peripheral T-cell lymphoma
PV	polycythemia vera
qPCR	Real-time Quantitative PCR
SMART-ddPCR	Somatic Mutation Allelic Ratio Test ddPCR
SNP	single nucleotide polymorphism
SS	sanger sequencing
STRs	short tandem repeats
TDS	targeted deep sequencing
TKI	tyrosine kinase inhibitors
VAF	variant allele fractions
WM	Waldenström Macroglobulinemia